<DOC>
	<DOCNO>NCT02985671</DOCNO>
	<brief_summary>The purpose study determine whether fix combination orphenadrine , acetaminophen , caffeine diclofenac sodium effective treatment acute episode mechanical postural low back pain Voltaren® . Will randomize 110 participant sex , age 18 year old less 65 year age acute episode mechanical postural low back pain allocate one two treatment group : Group 1 : Fixed combination orphenadrine , acetaminophen , caffeine diclofenac sodium ; Group 2 : Voltaren®</brief_summary>
	<brief_title>To Evaluate Superiority Fixed Combination ( Orfenadrine 35mg , Acetaminophen 325mg , Caffeine 65mg Diclofenac Sodium 50mg ) Compared Voltaren® ( Diclofenac Sodium 50mg ) Treatment Acute Postural Low Back Pain .</brief_title>
	<detailed_description>The fixed combination orphenadrine 35mg , acetaminophen 325mg , caffeine 65mg diclofenac sodium 50mg aim provide patient anti-inflammatory , analgesic myorelaxant action adequate safety tolerability profile . Diclofenac nonsteroidal anti-inflammatory analgesic , anti-inflammatory antipyretic action effective treatment variety acute chronic inflammatory painful condition . Its anti-inflammatory effect occur inhibit synthesis prostaglandin inhibit COX-1 COX-2 equipotent manner . Orphenadrine , hand , central act muscle relaxant analgesic anticholinergic effect . It present clinical efficacy treatment painful condition associate picture strain sprain , especially acute character , among musculoskeletal condition present pain muscular contracture . Concerning acetaminophen , drug analgesic antipyretic action well anti-inflammatory property . It widely use wide variety pathology focus treatment mild moderate pain . It non-opioid analgesic action inhibition cyclooxygenase consequently production prostaglandin , potency similar aspirin . It analgesic choice child , elderly pregnant woman . It use successfully treatment back pain . The association acetaminophen orphenadrine know clinically effective analgesia , well combination acetaminophen diclofenac , also provide clinical efficacy management acute postoperative pain . Lastly , caffeine , alkaloid belong group methylxanthines , agonist competes adenosine receptor , act receptor vary area , throughout peripheral circulation cerebral cortex . Caffeine enhance effect analgesic , improves acetaminophen pharmacokinetics , induces mood change . All mechanism may contribute improve analgesic action acetaminophen . The association non-steroidal anti-inflammatory , muscle relaxant , analgesic caffeine symptomatic treatment painful condition associate musculoskeletal system quite old .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Orphenadrine</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Ability understand consent participation clinical study , express signing Informed Consent Form ( ICF ) ; 2 . Patient acute low back pain responds pain period less equal 3 day minimum value 40 mm VAS ; 3 . Research participant perform simple RX lumbosacral spine , result within limit normality age group . 1 . Use illicit drug ; 2 . Fertile woman positive pregnancy test urine gestation breastfeeding ; 3 . Participants present allergic reaction , asthma urticaria response exposure aspirin , sulfonamides NSAIDs ; 4 . Women agree use acceptable contraceptive method ( oral contraceptive , intravenous contraceptive , intrauterine device ( IUD ) , hormonal implant , barrier method , hormonal transdermal patch tubal ligation ) ; except surgically sterile ( bilateral oophorectomy hysterectomy ) , menopause least one year , participant report engage sexual practice nonreproductive practice ; 5 . Participants inflammatory condition rheumatic condition know rheumatoid arthritis , osteoarthrosis ( grade II , III IV criterion Kellgren Lawrence , Annex IV ) , ankylose spondylitis psoriatic arthritis , chronic pain condition ( great six week ) , primary secondary neoplasia , moderate severe scoliosis ( great 40º ) , low back pain result trauma , visceral disorder dysmenorrhea endometriosis ; 6 . Known hypersensitivity component medicine use study ; 7 . Research participant bacterial infection recently ( last 90 day ) , affect spine , pelvic abdominal region ; well participant history bacterial infection affect spine chronic way ; 8 . Research participants previously diagnose herniated disc , osteoid osteoma , arthroscopic narrow spinal canal , spondyloarthropathies , spondylodiscites , renal calculus , calculitic cholecystitis , endometriosis , prostatitis , abdominal aortic aneurysm , chronic pelvic pain , pyelonephritis , perirenal abscess pancreatitis , rheumatoid arthritis , systemic lupus erythematosus , psoriatic arthritis , polymyalgia rheumatica , gout , episodes acute monoarthritis compatible pseudogout , Paget 's disease , septic arthritis , avascular necrosis , Wilson 's disease , hemochromatosis , alkaptonuria , primary osteochondromatosis , iritis , colitis , urethritis skin rash ; 9 . Participants present suspect previous history esophageal , gastric duodenal ulcer , bleed first dose study medication ; 10 . Research participant present chronic uncontrolled disease , diabetes , hypertension , chronic hepatic renal disorder , clinical condition , opinion investigator , may interfere study drug ; 11 . Participants present inflammatory bowel disorder ( eg , Crohn 's disease ulcerative colitis ) , significant coagulation defect history cardiovascular disease may prevent use NSAIDs , congestive heart failure ; 12 . Any finding clinical observation ( clinical / physical assessment ) interpret investigate physician risk participation research participant clinical study ; 13 . History lumbar spine surgery , nature ; 14 . Failure understand respond Roland Morris questionnaire , SF36 quality life questionnaire , Participant 's diary , accompany person assist / ; 15 . Participant history malignant disease without documentation remission / cure , eg , melanoma , leukemia , lymphoma , myeloproliferative disease renal cell carcinoma duration exclude ; 16 . Immunosuppressed participant ; 17 . Research participant perform treatment osteoporosis ; 18 . Diagnosis equine cauda syndrome / acute severe neurological deficit ( presence motor sensory change low limb positive Lasegue signal &gt; 60o ) . Sphincter anesthesia change saddle ; 19 . History intense pain minimal effort , progressive pain night persistent restriction movement ; 20 . Research participant unexplained weight loss ( 10kg three month ) ; 21 . Research participant perform type oral , physical topical treatment low back pain ( eg acupuncture , local heat yoga ) / initiation physiotherapy program last 2 month start study ; 22 . Participant research participate clinical study protocol last 12 ( twelve ) month ( CNS Resolution 251 , August 7 , 1997 , item III , subitem J ) , unless investigator deems may direct benefit To ; 23 . Use prohibit drug specify item 11.2 protocol . If participant make use acetylsalicylic acid , use antiplatelet agent , maximum dose 200mg allow ; 24 . Participant relationship kinship second degree bond employee employee Sponsor Research Center .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Postural Low Back Pain</keyword>
	<keyword>Mechanical Low Back Pain</keyword>
	<keyword>Low Back Pain</keyword>
	<keyword>acetaminophen</keyword>
	<keyword>caffeine</keyword>
	<keyword>orphenadrine</keyword>
	<keyword>diclofenac sodium</keyword>
</DOC>